Astellas Venture Management logo

Astellas Venture Management

Investments
53
Lead Investments
6

Astellas Venture Management (AVM) is the wholly-owned venture capital organization within Astellas Pharma, dedicated to supporting pre-clinical, cutting-edge science. AVM invests globally in the human therapeutics field, actively seeking new investment opportunities to drive scientific innovation.

Founded 2005
North America, United States
1-10
astellasventure.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Therapeutics
Medical
Pharmaceutical

Investment Types

Early Stage Venture
Late Stage Venture
Private Equity

Notable Investments

Sidewinder Therapeutics logo
Orna Therapeutics logo
Oncorus logo
Avilar Therapeutics logo
Twentyeight-Seven Therapeutics logo
TScan Therapeutics logo
Viamet Pharmaceuticals logo
Shinobi Therapeutics logo
Casma Therapeutics logo
PhoreMost logo
Effector Therapeutics logo
Nereus Pharmaceuticals logo
Tizona Therapeutics logo
Cleave Therapeutics logo
Catamaran Bio logo

Investment History

Team